EGFR Tyrosine Kinase Inhibitor Efficacy in Older Adult Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer: A Meta-Analysis and Systematic Review
<i>Background and Objectives</i>: Lung cancer remains the most common malignancy worldwide. As the global population ages, the prevalence of epidermal growth factor receptor (EGFR)-mutation-positive non-small cell lung cancer (NSCLC) is increasing. <i>Materials and Methods</i>...
| Autores principales: | , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
MDPI AG
2022-11-01
|
| Colección: | Medicina |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/1648-9144/58/11/1645 |